An agreement struck between the UK and EU on Northern Ireland has been welcomed by the British Generic Manufacturers Association as offering certainty for the industry and patients, easing pressures that had threatened to make supply to the region unviable.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?